Abstract
Objective: To describe clinical features acute hypertensive basal ganglia intracerebral hemorrhage. Subjects and methods: a descriptive study of 121 patients with acute hypertensive basal ganglia intracerebral hemorrhage at Department of Neurology, Bach Mai Hospital from June 2021 to December 2022.
Results: The mean age of the study group was 59.6 ±11.5. Male/Female ratio 1.9. Research shows that the rate of deterioration in the age group ≥ 65 is 51.4%, 2.5 times higher than the age group < 65 years old. Hematoma volume ≥ 60 cm3 and hematoma size ≥ 3cm are severe prognostic factors. There is a difference between the two progression groups, this difference is statistically significant (p > 0.05). The rate of deterioration in the group of patients with hematoma midline shift ≥ 5mm (67.6%) is 6.6 times higher than the group of patients with hematoma midline shift < 5mm.
Conclusion: The study was conducted on 121 patients with acute hypertensive basal ganglia intracerebral hemorrhage treated at Bach Mai Neurological Center from July 2021 to December 2022. The average age of the research group was 59,6 ± 11,5 years old. Male/female ratio 1.9. The results show that valuable factors in predicting poor outcome in patients with acute hypertensive basal ganglia intracerebral hemorrhage treated include: age ≥ 65, hematoma size ≥ 3cm, hematoma volume ≥ 60 cm3, midline shift ≥ 5mm.